Taho Pharma’s apixaban oral strips equivalent to Eliquis in pivotal trial
The Taiwanese company saw its oral dissolvable strip, TAH3311, meeting the standards as Pfizer’s Eliquis.
18 February 2025
18 February 2025
The Taiwanese company saw its oral dissolvable strip, TAH3311, meeting the standards as Pfizer’s Eliquis.
Merging industry-leading business intelligence & award-winning journalism, this is an unrivalled opportunity for engagement with B2B professionals across a network of 40+ leading media websites.
Steer your business strategy with key data and insights from our latest market research reports and company profiles. Not ready to buy? Start small by downloading a sample report first.
Give your business an edge with our leading industry insights.